Supporting evidence
Revenue changed +8.0% from the same quarter last year, through 2026-07-31. The previous quarterโs year-on-year change was +5.9%.
Donaldson Company Inc
-1.8% vs the weekly close ยท Price only, before dividends
Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance, business evidence, earnings support.
The assessment, supporting evidence and main risks.
The central value is below the share price. A sufficiently complete, positive earnings record allows the stock's own P/E history to be used.
Quarterly sales are growing, but capital spending changes the cash picture.
Company observations use the financial and market dates shown in the evidence. They may be newer than the published assessment.
Revenue changed +8.0% from the same quarter last year, through 2026-07-31. The previous quarterโs year-on-year change was +5.9%.
Operating cash covers 1.09 times profit, but cash after capital spending covers 0.94 times. Cash generation is stronger before the investment bill is paid.
Revenue changed +8.0% from the same quarter last year, through 2026-07-31. The previous quarterโs year-on-year change was +5.9%.
Enterprise value / EBITDA is 16.0ร for DCI, versus a peer median of 18.7ร. Its operating margin is 15.6% versus 17.8%. Business mix and growth expectations can explain the difference.
Over one year, the stock changed +10.4% against +13.7% for Industrials (XLI). The gap is -3.3 percentage points. These are price returns, before dividends.
Enterprise value / EBITDA is 16.0ร for DCI, versus a peer median of 18.7ร. Its operating margin is 15.6% versus 17.8%. Business mix and growth expectations can explain the difference.
Check the supporting chartCash after capital spending / profit: 0.9ร for DCI, against 1.2ร across 12 comparable peers.
Check the supporting chartNet debt / EBITDA: 1.5ร for DCI, against 1.7ร across 12 comparable peers.
Check the supporting chartOperating cash covers 1.09 times profit, but cash after capital spending covers 0.94 times. Cash generation is stronger before the investment bill is paid.
Check the supporting chartOver one year, the stock changed +10.4% against +13.7% for Industrials (XLI). The gap is -3.3 percentage points. These are price returns, before dividends.
Check the supporting chartRevenue changed +8.0% from the same quarter last year, through 2026-07-31. The previous quarterโs year-on-year change was +5.9%.
Check the supporting chartNet income was 129.3m, compared with 114.3m in the same quarter last year. Amounts are in USD.
Check the supporting chartOver the latest four quarters, operating cash was 1.09 times net income. Review receivables, inventory and non-cash charges before judging the gap.
Check the supporting chartOver 1 year (2025-09-12 to 2026-09-11), price changed +10.4% and trailing EPS changed +8.2%. A wider gap changes the earnings multiple; it does not establish fair value.
Check the supporting chartThe estimate for the period ending 2027-07-31 changed -0.9% over 30 days. Coverage is 7 analysts.
Check the supporting chartThe latest quarterly operating margin was 17.2%, +1.8 percentage points from a year earlier. Compare the sales and margin contributions below.
Check the supporting chartOf the latest 4 comparable quarters, 3 beat the estimate and 1 missed it. Check how price responded; a beat alone is not a reason to buy.
Check the supporting chartDebt less cash was 1,074.4m at 2026-07-31. Operating profit covered interest 16.8 times.
Check the supporting chartValuation comments use the starting assumptions. Related findings can reflect the same underlying change; they are not separate votes or a probability of success.
SM Virtual Analyst is an automated review of stored company results and market data. The views below describe the available evidence and identify what to check next.
Revenue, profit, cash generation and the operating measures behind them.
Follow the operating evidence, compare results with recorded forecasts, and check what funds growth.
Sales, profitability and cash after investment, compared with the financial history.
Donaldson Company, Inc. manufactures and sells filtration systems and replacement parts worldwide. The company is headquartered in Bloomington, Minnesota.
Capital spending changes the cash picture. Operating cash covers 1.09 times profit, but cash after capital spending covers 0.94 times. Cash generation is stronger before the investment bill is paid.
The same twelve-month reporting period. Cash after capital spending is before dividends, buybacks and debt repayments.
Latest reported margin 15.6% ยท Annual-history median 14.0%
The latest twelve-month period is the same as the last annual result, so it appears once. The median describes the available history; it is not an assumed future margin.
The latest reporting periods, earnings quality and the longer financial record.
Start with the latest quarters, then check whether the longer record supports the same view.
Compare completed quarters with the same periods a year earlier. Annual year-end: 2026-07-31.
Reported revenue in USD. Growth can include acquisitions, exchange-rate changes and price changes.
Operating profit shows the business before financing and tax. Net income can also reflect asset sales and other one-off items.
Latest quarter against the same quarter last year. The sales effect holds the old margin fixed; the remaining change comes from the margin. These two amounts add up to the change in operating profit.
Cash can move sharply between quarters. Check the four-quarter comparison and working-capital changes before drawing a conclusion.
Same quarter one year earlier. Receivables and inventory are balances at the reporting date; sales cover the quarter. Faster growth can tie up cash, but acquisitions and payment timing can also explain a change.
Year-to-date comparisons require every completed quarter since the annual year-end and a matching prior-year period. Missing periods are not treated as zero. Figures may include subsequent restatements.
Annual revenue changed +5.3% between the latest two reported years.
See the figures โOperating profit was 15.4% of revenue, a change of +2.0 percentage points.
See the figures โOperating cash flow was 1.09 times net income. Working capital and non-cash charges can explain the difference.
See the figures โReported financial years. Amounts in USD.
The proportion of sales left as operating profit and cash after capital spending.
Cash after capital spending still has to cover debt repayments and other commitments.
Cash spent, shown as positive amounts. Compare buybacks with changes in the diluted share count.
Inventory and receivables as a percentage of annual sales. Increasing amounts can tie up cash; business seasonality also matters.
| Financial year | Revenue | Operating profit | Net income | Operating cash | Cash after capital spending | Diluted shares | Published |
|---|---|---|---|---|---|---|---|
| 2019-07-31 | 2844900000.0 | 388200000.0 | 267200000.0 | 345800000.0 | 195400000.0 | โ | 2019-09-05 |
| 2020-07-31 | 2581800000.0 | 340100000.0 | 257000000.0 | 387000000.0 | 264600000.0 | โ | 2020-09-03 |
| 2021-07-31 | 2853900000.0 | 384700000.0 | 286900000.0 | 401900000.0 | 343600000.0 | โ | 2021-09-02 |
| 2022-07-31 | 3306600000.0 | 443500000.0 | 332800000.0 | 252800000.0 | 167700000.0 | โ | 2022-08-31 |
| 2023-07-31 | 3430800000.0 | 480200000.0 | 358800000.0 | 544500000.0 | 426400000.0 | โ | 2023-08-29 |
| 2024-07-31 | 3586300000.0 | 544100000.0 | 414000000.0 | 492500000.0 | 406900000.0 | โ | 2024-08-28 |
| 2025-07-31 | 3690900000.0 | 495400000.0 | 367000000.0 | 418800000.0 | 339900000.0 | โ | 2025-08-27 |
| 2026-07-31 | 3885600000.0 | 599900000.0 | 453800000.0 | 493700000.0 | 426300000.0 | โ | 2026-08-26 |
Amounts use each statementโs reported currency. Historical figures can include later restatements. Weighted diluted shares are an annual earnings measure, not the current share count used for valuation.
Separate the operating result, financing, tax and share count. Compare the same quarter a year apart.
Its contribution was $30.80m. The bridge reconciles the two quarters; it does not by itself establish whether the change will repeat.
See the figures โThe latest quarter reported $129.30m net income and $199.90m operating cash. The difference includes non-cash expenses and working capital; one quarter can be seasonal.
See the figures โUSD. Components add up to the total change. Non-operating items can include interest, investment income and other gains or charges.
USD. Cash timing can differ from profit recognition. Use several quarters to check whether a difference persists.
No reviewed schedule of unusual profit items is recorded. Reported profit is not assumed to be recurring profit.
Growth from pricing, volume, acquisitions and currency is identified only when the company provides a matching breakdown. A financial bridge explains the arithmetic, not the business cause. Gains are positive and charges negative in the unusual-item schedule.
Compare the cash generated by the business with investment, acquisitions, dividends and buybacks.
Cash after capital spending is before acquisitions, dividends and buybacks. A full remaining-cash figure is shown only when all those amounts are matched; missing payments are never zero. A shortfall may be met by cash balances, borrowing or asset sales. These figures do not establish the funding source or the return on new investment.
These cash measures show funding needs. They do not calculate the return on new investment. That requires comparable invested capital, after-tax operating profit and a supported required return. Acquisitions, disposals and accounting changes need separate treatment. Check the return-on-capital comparison in Peers & sector where those inputs are available.
A target is useful only when you can see the business assumptions behind it.
Recent median quarterly year-on-year growth; model starting growth. Published model assumptions; target date 2027-09-15.
Trailing result; margin at the target date. Published model assumptions; target date 2027-09-15.
Company guidance and consensus are compared only when the fiscal period, measure, currency and earnings basis match. Target assumptions below use their own stated horizon; they are not relabelled as fiscal-year consensus.
No verified, like-for-like management and consensus comparison is available yet. It is omitted rather than combining different periods or earnings definitions.
Performance, earnings and valuation compared with the market and other companies.
Separate the companyโs move from the wider market. Then examine the change in earnings and the price paid for them.
Both series start at 100 on the same date. Completed weekly prices; dividends are excluded. A sector fund represents its own holdings and weighting, which differ from the equally weighted sector statistics above.
At the old earnings multiple, the latest trailing EPS would imply $87.44. The actual close was $89.25.
2025-09-12 to 2026-09-11. The earnings contribution holds the starting P/E fixed; the remaining change comes from the P/E. This is an accounting comparison, not a fair-value estimate or proof of why investors traded.
-18.5% from the highest weekly close; 11.7% above the lowest.
Position in the range is useful context. It does not establish whether the business is cheap or expensive.
Test what the business could be worth โCompare reported earnings, the marketโs response and changes in expectations.
Weekly prices are matched only after a recorded results date. A reporting-week move includes other news. EPS from earnings releases may differ from statutory diluted EPS. Historical revisions can change this comparison; it is not a trading backtest.
3 beats and 1 misses across the last 4 comparable quarters. Earnings-release figures may use an adjusted basis and differ from the financial statements.
From the weekly close before the announcement to the first weekly close after it, and to approximately four weeks later. These are weekly-window returns, not a one-day reaction. Other news also affects price.
P/E is available for 157 of 157 weekly observations. There are no missing earnings observations in this displayed period. Select Trailing EPS to inspect the earnings behind the ratio.
P/E at 2026-09-11: 22.4ร ยท Median across positive-earnings weeks: 22.0ร. Loss-making weeks are excluded from this median.
Uses earnings-release EPS, which can differ from the statement EPS used in peer factors. A low multiple can reflect weaker expected earnings.
Price return excludes dividends. Earnings growth and multiple changes require positive EPS at both ends of the comparison.
Weekly prices are matched only after a recorded results date. A reporting-week move includes other news. EPS from earnings releases may differ from statutory diluted EPS. Historical revisions can change this comparison; it is not a trading backtest.
Compare the price of the business with what it earns. Then check whether the wider sector is helping.
Enterprise value / EBITDA is 16.0ร for DCI, versus a peer median of 18.7ร. Its operating margin is 15.6% versus 17.8%. Business mix and growth expectations can explain the difference.
DCI is the larger teal dot. Each other dot is a named peer. Move right for greater profitability; move up for a higher valuation multiple.
DCI is shown in teal. The comparison uses 12 selected peers out of 61 other covered listings in Specialty Industrial Machinery.
Active US common listings in the same industry; up to 12 peers nearest in market value. Identified preferred shares, warrants, rights and units are excluded. Matching company names and labelled share classes count once, using the listing with the largest stored market value; the target's other identified classes are excluded. This metadata screen is not a complete issuer-identity check. Medians require at least three companies per measure. All use the same published week and factor universe. Financial periods can differ and are shown below. This is a comparison of current constituents, not a backtest.
These figures cover other active US listings in the same sector and publication week. Sector membership is broader than the selected industry peers.
Percentage measures from the same published week. Profitability, growth and price performance describe different things; they are not added together.
Operating marginDCI 15.6% ยท Sector median 7.0%521 other listings with this measure
Adjusted-price change over one yearDCI 11.5% ยท Sector median 6.7%530 other listings with this measure
Comparisons use stored statement-based factors. Earnings-release EPS can use a different basis from these financial statements. Missing measures and unprofitable earnings multiples are omitted. Financial periods differ across issuers; matching publication weeks does not make their businesses identical.
Compare the trade-offs across closely sized businesses in the same industry. This list is not an investment ranking.
The trade-off is less favourable operating margin, net debt / ebitda.
RRX financial period 2026-06-30. Published prices 2026-09-11. Differences in product mix, geography and accounting can limit comparability.
Read RRX's case โ| Measure | DCI | RRX |
|---|---|---|
| EV / EBITDA | 16.04ร | 12.48ร |
| Operating margin | 15.59% | 11.74% |
| Net debt / EBITDA | 1.51ร | 3.57ร |
The trade-off is less favourable ev / ebitda, operating margin, net debt / ebitda.
GNRC financial period 2026-06-30. Published prices 2026-09-11. Differences in product mix, geography and accounting can limit comparability.
Read GNRC's case โ| Measure | DCI | GNRC |
|---|---|---|
| EV / EBITDA | 16.04ร | 21.40ร |
| Operating margin | 15.59% | 9.50% |
| Net debt / EBITDA | 1.51ร | 2.18ร |
The trade-off is less favourable ev / ebitda, operating margin, net debt / ebitda.
FLS financial period 2026-06-30. Published prices 2026-09-11. Differences in product mix, geography and accounting can limit comparability.
Read FLS's case โ| Measure | DCI | FLS |
|---|---|---|
| EV / EBITDA | 16.04ร | 19.08ร |
| Operating margin | 15.59% | 12.85% |
| Net debt / EBITDA | 1.51ร | 2.72ร |
The trade-off is less favourable ev / ebitda.
CR financial period 2026-06-30. Published prices 2026-09-11. Differences in product mix, geography and accounting can limit comparability.
Read CR's case โ| Measure | DCI | CR |
|---|---|---|
| EV / EBITDA | 16.04ร | 22.83ร |
| Operating margin | 15.59% | 17.93% |
| Net debt / EBITDA | 1.51ร | 1.40ร |
Check business mix, accounting and future growth before drawing an investment conclusion.
PNR financial period 2026-06-30. Published prices 2026-09-11. Differences in product mix, geography and accounting can limit comparability.
Read PNR's case โ| Measure | DCI | PNR |
|---|---|---|
| EV / EBITDA | 16.04ร | 10.89ร |
| Operating margin | 15.59% | 19.50% |
| Net debt / EBITDA | 1.51ร | 1.70ร |
The trade-off is less favourable ev / ebitda.
WTS financial period 2026-06-30. Published prices 2026-09-11. Differences in product mix, geography and accounting can limit comparability.
Read WTS's case โ| Measure | DCI | WTS |
|---|---|---|
| EV / EBITDA | 16.04ร | 19.96ร |
| Operating margin | 15.59% | 19.24% |
| Net debt / EBITDA | 1.51ร | -0.41ร |
The published target, its assumptions and alternative valuation methods.
The lower valuation comes with weaker profitability. Quarterly sales are growing, but capital spending changes the cash picture.
A sufficiently complete, positive earnings record allows the stock's own P/E history to be used.
The weaker case combines slower sales, lower margins and a lower P/E. The range uses business-specific sensitivity assumptions. Severe stress is shown separately. These are not probabilities or limits on possible losses.
Trailing release EPS to the central estimate. Assumes the share count and the relationship between release earnings and statement profit stay unchanged.
See the evidence โCurrent P/E compared with the median of the usable weekly record. The unchanged-P/E comparison separates earnings growth from a change in valuation. History alone does not establish a justified future multiple.
See the evidence โThe business-specific cash and borrowing assessment is shown with the rating evidence.
See the evidence โ-0.1% annual sales growth ยท 10.0% net margin ยท 19.8ร earnings
4.9% annual sales growth ยท 11.1% net margin ยท 22.0ร earnings
9.9% annual sales growth ยท 12.2% net margin ยท 24.2ร earnings
First change earnings at today's P/E, then change the P/E. The contributions add up to the difference between the latest close and the target.
Net income divided by revenue. The central assumption moves halfway from the latest margin towards the median of 5 annual results, including loss years.
| Scenario | Sales growth / year | Net margin | Estimated EPS | P/E | Price |
|---|---|---|---|---|---|
| Weaker | -0.1% | 10.0% | $3.39 | 19.8ร | $67.18 |
| Central | 4.9% | 11.1% | $3.98 | 22.0ร | $87.62 |
| Stronger | 9.9% | 12.2% | $4.61 | 24.2ร | $111.73 |
Methods are considered by business suitability and completeness of evidence. The model does not select whichever produces the highest target.
| Method | Input checks | Outstanding requirements |
|---|---|---|
| Earnings and historical valuation ยท Selected | Passed | Required inputs are available. Publication safeguards apply separately. |
| Cash flow across the cycle | Incomplete | Recorded cash-flow, investment, debt, cash, preferred stock, minority interests and share-count inputs are required; missing amounts are not assumed to be zero. Missing: minority interest. |
The model estimates earnings for the 12-month period ending on the target date, then applies a P/E from this stock's own weekly history. It uses the same earnings-release EPS basis for both. Other valuation methods below remain separate comparisons.
Sales growth starts at the median of the latest four quarterly year-on-year changes, limited to โ20% to +30%. The central net margin moves halfway towards the median of up to five annual results. Projected statement profit changes are applied proportionally to trailing release EPS, assuming a constant share count and earnings basis. Reporting lag is included in the projection period.
The central multiple is the median usable historical P/E. Ordinary weaker and stronger cases vary growth, margin and P/E around the central assumptions using observed dispersion and the stated business-specific minimum bands. The combined sales contraction and multiple shock is a separate severe stress. These are explicit SM assumptions, not analyst consensus.
Historical profits may contain unusual items. Neither a historical median nor the reconciliation thresholds establish recurring earnings. Changes in the business, dilution, acquisitions or accounting treatment can invalidate the assumptions.
Buy requires the disclosed return hurdle, at least equal upside to the weaker-case decline, sound cash and borrowing, and evidence of profitable growth, cash value or operating recovery. Hold + Add requires at least three quarters of the Buy hurdle (minimum 10%), upside of at least three quarters of the weaker-case decline, positive cash and acceptable borrowing, without declining growth evidence. Hold + Reduce means at least 10% central price downside without meeting Sell. Sell requires at least 25% downside, or at least 15% with declining growth or both losses and negative cash after investment; central downside must also cover any upside in the stronger ordinary scenario. Hold covers the remaining rated cases. The qualified Hold ratings express direction and do not specify a position size. Moderate borrowing up to 1.0 times above the business limit can support Hold + Add only with interest cover of at least 6 times and cash after investment of at least 10% of net debt. High valuation uncertainty adds five percentage points to the Buy hurdle. Severe stress is separate. Returns are price only; unverified dividends are not added.
Publication safeguards. Model estimates below one quarter or above four times the current price require a separate valuation review. Cash-flow estimates also require review when more than 90% of their absolute present value comes from after year five. These are SM review thresholds; they do not cap the calculated value or move it towards the market price.
This is an automated research assessment. The policy has not yet been validated against subsequent stock returns. It does not account for your portfolio, tax position or investment needs.
New data refreshes the evidence. A formal review determines whether the published assessment changes. Editing the valuation controls below changes your scenario only. Saving your case preserves this dated assessment alongside your assumptions.
| Check | Status | Evidence |
|---|---|---|
| Recent price | Passed | Weekly close dated 2026-09-11. |
| Suitable business model | Passed | Value operating cash flow or comparable earnings; deduct debt and other ownership claims where appropriate. |
| Four quarters | Passed | Four quarters ending 2026-07-31. Open evidence โ |
| Current financials | Passed | Statements through 2026-07-31; factor prices dated 2026-09-11. |
| Annual record | Passed | 5 consecutive annual profit margins, including loss years. Open evidence โ |
| Comparable earnings history | Passed | P/E is usable in 157 of 157 weeks. At least 52 usable weeks and 70% coverage are required; excluding too many loss or missing weeks would bias the target. Open evidence โ |
| Earnings and price dates | Passed | Earnings-release EPS $3.98, for four quarters ending 2026-07-31. |
| Price risk | Passed | Risk uses the latest 52 weekly price changes. |
| Comparable sales growth | Passed | Growth uses the median of four quarterly year-on-year comparisons. |
| Positive statement earnings | Passed | Trailing statement profit is positive. |
| Earnings reconciliation | Passed | Release EPS is $3.98; statement-derived EPS is $3.92. The difference is within the 5% review threshold; this does not prove there are no unusual items. Open evidence โ |
| Statement totals | Passed | The latest four quarters agree with the trailing snapshot within 5%. |
| Cash and borrowing | Passed | Cash generation, debt and interest-cover figures are available. Open evidence โ |
| Target publication review | Passed | The model estimate is within SM's automatic publication range of one quarter to four times the current price. This is a review threshold, not evidence that the market price is correct. |
Financial period: 2026-07-31. P/E history: 2023-09-15 to 2026-09-11; 157 usable weeks out of 157. Model version: sm-assessment-14-operating-capital. Published price: $89.25 on 2026-09-11. The upside above uses the latest close. Review policy and original record โ
The central value is below the share price. Hold ยท Earnings and historical valuation
Classification sensitivity. The classification changes under the tested assumptions. View the comparisons โ
Weekly close $89.25. The figures below make the model's value at 2027-09-15 equal this price.
| Assumption | Our model | To match price |
|---|---|---|
| Multiple on model EPSHolds projected annual EPS at $3.98. | 22.02ร | 22.42ร |
| Annual EPS at model multipleHolds the earnings multiple at 22.02ร. | 3.98 USD | 4.05 USD |
These are alternative ways for the target-date value to equal the latest weekly close, before dividends. They imply zero price appreciation to that date, not an investor's required total return. Each changes one assumption while holding the others fixed. Many combinations could fit the price; this does not establish market consensus or the likelihood of an outcome.
Target $87.62 for 2027-09-15. Assessment 2026-09-16; financial period through 2026-07-31.
| Measure | Evidence | Assumption |
|---|---|---|
| Sales growth | 4.89% | 4.89% |
| Net profit margin | 11.68% | 11.07% |
| Earnings multiple | 22.02ร historical reference | 22.02ร |
These inputs use the reporting period, profit adjustments and share basis recorded at assessment. Historical averages do not establish sustainable growth or margins.
Sales growth. Median of 4 recorded year-on-year comparisons. Assumed annual growth through the target date, including the reporting lag.
Net profit margin. Historical reference: 10.46%. Margin assumed at the target date.
Earnings multiple. Applied to projected annual EPS of $3.98. This is a model forecast.
Company evidence recorded with the assessment on 2026-09-16. The detailed financial tables may contain newer results.
Quarterly sales are growing. Revenue changed +8.0% from the same quarter last year, through 2026-07-31. The previous quarterโs year-on-year change was +5.9%.
Capital spending changes the cash picture. Operating cash covers 1.09 times profit, but cash after capital spending covers 0.94 times. Cash generation is stronger before the investment bill is paid.
Strength in the business and an attractive share price are separate judgments. These findings do not independently verify the target.
The two assumptions with the largest effect in the sensitivity tests, measured relative to our target. The table shows both ends of each range. Other assumptions stay fixed; these are conditional values, not forecasts or probabilities.
| Measure | Changed assumption | Target-date value |
|---|---|---|
| Net margin | Profit margin: 9.96%Use the ordinary scenario margin assumptions with other central assumptions fixed. | $78.86 |
| Net margin | Profit margin: 12.18%Use the ordinary scenario margin assumptions with other central assumptions fixed. | $96.39 |
| These values fall on both sides of the latest weekly close. | ||
| Historical earnings multiple | Earnings multiple: 19.81รUse the ordinary scenario multiples without changing the earnings forecast. | $78.86 |
| Historical earnings multiple | Earnings multiple: 24.22รUse the ordinary scenario multiples without changing the earnings forecast. | $96.39 |
| These values fall on both sides of the latest weekly close. | ||
Rating basis recorded 2026-09-16. Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance, business evidence, earnings support.
| Measure | At publication | Latest | Improvement threshold | Deterioration threshold | Status |
|---|---|---|---|---|---|
| Quarterly sales growth | 7.96% | 7.96% | โฅ 12.96% | โค 2.96% | Within starting range |
| Quarterly operating margin | 17.24% | 17.24% | โฅ 19.24% | โค 15.24% | Within starting range |
| Operating cash / profit | 1.09ร | 1.09ร | โฅ 1.29ร | โค 0.89ร | Within starting range |
| Net debt / EBITDA | 1.51ร | 1.51ร | โค 1.01ร | โฅ 2.01ร | Within starting range |
These observations use the stated periods and reporting bases. Reported margins and the valuation's adjusted margin history can differ; reconcile the basis before comparing a new result with the model.
New results, restatements, material disclosures and unresolved share changes require review. A sustained price change can change the rating comparison without changing the target. Company evidence, risk and uncertainty must still support the classification. Dividends are assessed separately where verified.
Growth, cash generation, borrowing and uncertainty behind the rating.
Value operating cash flow or comparable earnings; deduct debt and other ownership claims where appropriate.
A complete positive per-share earnings comparison is unavailable.
The scenario range and valuation dependence are within the standard review bands. This does not measure the probability of reaching the target.
The published recommendation is Hold. The checks below compare its recorded company assumptions with the latest weekly close. A formal review is required before the recommendation changes.
Using the model's projected EPS and today's P/E gives $89.25, compared with the $87.62 target. The difference requires a change in the earnings multiple. Projected EPS changes 0.0% between the financial-period end and the target date.
Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance, business evidence, earnings support.
Valuation uncertainty is standard. The scenario balance does not measure the probability of reaching either value. A Sell can reflect a high price for a sound company; Hold can reflect insufficient support for a positive view despite a higher target.
| Classification | Current comparison | Meaning and requirements |
|---|---|---|
| Buy | Does not apply | Positive value with sufficient business and financial support. At least 15.0% central upside, covering the 24.7% weaker-case decline; cash, borrowing and a supported business route must pass. |
| Hold + Add | Does not apply | Qualified positive value; full Buy requirements are not met. At least 11.2% upside and three quarters of the weaker-case decline, positive cash, acceptable borrowing and no declining growth evidence. |
| Hold | Applies | No directional classification meets its requirements. This can reflect a price near the target, an insufficient return margin or financial evidence that does not support a positive view. It is not a substitute for missing valuation data. |
| Hold + Reduce | Does not apply | Qualified negative value; full Sell requirements are not met. At least 10% central downside, without both the 25% Sell threshold and its stronger-case balance. |
| Sell | Does not apply | Substantial negative value, with the stronger scenario checked. At least 25% central downside and at least as much downside as the 25.2% stronger-case upside. Declining evidence: not established. |
| Assessment | Buy requirement | Evidence |
|---|---|---|
| Price and return | Not met | -1.8% price upside against a 15.0% Buy requirement. |
| Downside balance | Not met | The weaker operating case is 24.7% below the price. Severe stress is shown separately. |
| Cash generation | Met | Positive cash after capital spending and at least 80% cash conversion of positive reported profit are required. |
| Borrowing | Met | Sound. The operating company policy uses net debt / EBITDA up to 3.0 and interest cover of at least 4.0, unless cash covers debt. |
| Business evidence | Not met | Further evidence needed. Growth evidence: mixed. |
| Earnings support | Not met | A growth Buy needs at least 5% annual model EPS growth; a cash-value case uses its separate cash-yield requirement. |
Price return relative to the requirement: -0.12ร. A value of 1 meets the return hurdle; it does not establish a Buy on its own. The comparison excludes dividends, fees and taxes. Hold + Add means a measured positive research view with less support than Buy. Hold + Reduce means a qualified negative view where the full Sell requirements are not met. These labels do not specify a holding size or assume you already own the stock.
EPS divided by price is earnings yield: $5 of earnings at a $100 price is 5%. Earnings are not a promised distribution. Cash after capital spending is before debt principal repayments. Neither yield is added to earnings growth to calculate a return.
| Measure | Yield | Period |
|---|---|---|
| Reported earnings yieldReported annual earnings / listed share price | 4.5% | 2026-07-31 |
| Cash after capital spending / priceOperating cash less capital spending; before debt principal payments and distributions | 4.2% | 2026-07-31 |
| Model earnings yield at today's priceModel EPS at target date; not consensus or reviewed recurring earnings | 4.5% | 2027-09-15 |
| Historical earnings yieldInverse of the median usable historical P/E; not a required investment return | 4.5% | 2026-09-11 |
A recurring-earnings yield needs a reviewed adjustment schedule. Consensus is included only with verified currency, annual period, earnings definition and listed-share basis. Unknown inputs remain excluded.
A comparable after-tax operating return on current capital is unavailable. Returns on new investment and organic growth are not inferred from revenue growth.
Sales growth uses comparable reported periods. Earnings and cash growth use two years per diluted share, where complete; a comparison spanning a split is excluded until a common basis is verified. Periods with conflicting earnings and share units are excluded from both per-share comparisons. These observations do not establish organic growth or returns on new investment. Projected EPS change covers the financial-period end to the target date.
Growth must be funded. The cash-flow model charges for investment and working capital; an earnings target holds shares constant and is checked against cash generation. Organic growth, acquisition effects and the return on new investment are not inferred from sales growth alone. Missing evidence does not receive a positive score.
| Year end | Diluted EPS | Cash after capital spending / diluted share |
|---|---|---|
| 2022-07-31 | Unavailable | Unavailable |
| 2023-07-31 | Unavailable | Unavailable |
| 2024-07-31 | Unavailable | Unavailable |
| 2025-07-31 | Unavailable | Unavailable |
| 2026-07-31 | Unavailable | Unavailable |
Cash coverage: 1.09ร (reported net profit). Net debt / EBITDA: 1.51ร. Interest cover: 16.83ร. Cash covering debt outright also meets the borrowing requirement. Otherwise the business policy uses a leverage limit of 3.0ร and interest cover of 4.0ร. Borrowing up to 1.0ร above the limit may support Hold + Add only when interest cover is at least 6ร and annual cash after capital spending covers at least 10% of net debt.
The reported debt amount is retained. Lease obligations are not silently removed.
The ordinary scenarios widen with observed growth and margin dispersion. The minimum sales-growth band is 5 percentage points for this business. The minimum margin band is 10% of the central margin. Earnings cases also use at least a 10% P/E band. Cash-flow cases use a half-point discount-rate band, keeping 2% continuing growth and spending-floor assumptions consistent. These are disclosed sensitivity assumptions, not statistical confidence intervals.
Growing businesses can qualify through persistent reported growth and improving per-share earnings or cash. Established businesses can qualify through cash value. A cash-flow recovery needs supportive operations without additional forecast borrowing. A growth Buy requires at least 5% annual model EPS growth. The target bridge shows the separate effect of any change in P/E.
This combines a sales contraction, weaker profit margins and a reduction of at least 25% in today's P/E. The original severe downside assumptions remain available for assessing vulnerability.
Model value: $47.56 ยท -46.7% relative to the weekly close.
Sales growth -10.0% ยท margin 9.3% ยท P/E 16.8ร. This scenario has no assigned probability and is not a limit on possible losses.
The target and classification use price returns. This separate comparison adds only reviewed regular cash dividends with an eligible ex-date and payment by the target date.
Dividend evidence incomplete. No dividend-inclusive figure is shown. Missing or ineligible payments are not treated as zero income, and a historical dividend yield is not used as a forecast.
Smaller changes in the tested assumptions. These tests use the assessment recorded on 2026-09-16.
Each test changes only the stated assumptions. These are conditional values, not a confidence interval or the probability of reaching a target. A change above 25% of the central target is flagged for review. The central earnings and multiple assumptions are retained.
The classification changes under the tested assumptions.
| Assumption | Central value | Rating |
|---|---|---|
| Net margin ยท lower input | $78.86 | Hold + Reduce |
| Historical earnings multiple ยท lower input | $78.86 | Hold + Reduce |
| Net margin ยท higher input | $96.39 | Hold |
Each alternative includes its own weaker and stronger cases. These are conditional comparisons, not probabilities or new recommendations.
The vertical marker is the central target of $87.62. Each range changes one input or the stated pair of capital ratios. All other assumptions stay fixed.
| Method | Value / share |
|---|---|
| Earnings and historical valuationSelected method | $87.62 |
| Cash flow across the cycle | Not comparable |
A second method has not passed all the requirements. Agreement between valuation methods has not been established.
Same target date, separate methods. Earnings history uses a historical P/E; operating cash flow models investment and financing. They share company data and are not independent appraisals. No average is used and no method is selected because it gives a higher value.
Earnings and historical valuation ยท Checks passed
Cash flow across the cycle ยท Not comparable
Recorded cash-flow, investment, debt, cash, preferred stock, minority interests and share-count inputs are required; missing amounts are not assumed to be zero. Missing: minority interest.
The tested values fall on both sides of the review price of $89.25. These comparisons do not replace the published target or rating.
| Test | Assumption | Value | Change vs target |
|---|---|---|---|
| Sales growth ยท lower input | Use the ordinary scenario growth assumptions while holding the other central assumptions fixed.Sales growth: -0.11% | $82.94 | -5.3% |
| Sales growth ยท higher input | Use the ordinary scenario growth assumptions while holding the other central assumptions fixed.Sales growth: 9.89% | $92.34 | 5.4% |
| Net margin ยท lower input | Use the ordinary scenario margin assumptions with other central assumptions fixed.Profit margin: 9.96% | $78.86 | -10.0% |
| Net margin ยท higher input | Use the ordinary scenario margin assumptions with other central assumptions fixed.Profit margin: 12.18% | $96.39 | 10.0% |
| Historical earnings multiple ยท lower input | Use the ordinary scenario multiples without changing the earnings forecast.Earnings multiple: 19.81ร | $78.86 | -10.0% |
| Historical earnings multiple ยท higher input | Use the ordinary scenario multiples without changing the earnings forecast.Earnings multiple: 24.22ร | $96.39 | 10.0% |
| Latest margin persists | Retain the latest net margin instead of moving halfway to the historical reference.Profit margin: 11.68% | $92.46 | 5.5% |
| Historical margin | Use the full historical median margin. A non-positive margin cannot be valued by P/E.Profit margin: 10.46% | $82.79 | -5.5% |
Recorded amounts, model assumptions and unresolved economic questions are shown separately. This inventory does not certify recurring earnings or a competitive advantage.
4 of 4 measured sales comparisons are positive. The median is 4.9%.
Model treatment. Starting sales growth is 4.9%. It is applied through the target date, including the reporting lag.
Reported growth can include acquisitions, price changes and currency effects. It does not establish organic growth or the duration of a competitive advantage.
Latest margin 11.7%; historical reference 10.5%.
Model treatment. The central net margin is 11.1%.
Historical results retain losses and unusually strong years. A median does not establish recurring profit; acquisitions and changes in business mix can make earlier years less comparable.
The valuation retains the recorded debt and ownership-claim basis.
Model treatment. No lease liability is removed and no corresponding expense is added back by this review.
Any lease adjustment must change profit, assets and debt consistently. Acquired intangibles, minority interests and convertible securities can need company-specific treatment.
Current ownership and earnings share bases are reconciled by the publication checks.
Model treatment. The forecast holds the share count constant. It does not assume future buybacks or issue proceeds.
Unvested awards and future capital raising can change value per share. A share-compensation expense and a separate dilution charge must not count the same cost twice.
| Item | Annual amount ยท USD | % of sales | Treatment and limitations |
|---|---|---|---|
| Share compensation | $24,700,000 | 0.6% | The operating-profit model does not add back share compensation separately. Reported operating cash can include an add-back. A fixed future share count is an assumption; awards and repurchases need separate review. |
| Acquisitions | Not established | โ | Acquisitions are shown separately from capital spending. Reported sales growth is not assumed organic. The central forecast does not establish funding for future acquisitions. |
| Research spending | $76,100,000 | 2.0% | Reported research expense is retained in profit. It is not capitalised or added back without an explicit asset life and amortisation schedule. |
| Research excluding acquired projects | Not established | โ | This excludes acquired research. It is shown separately and is not substituted for total research spending. |
| Acquired research expense | Not established | โ | This is the reported expense for acquired research, not necessarily the cash paid in this period. It is not added back to profit. |
An annual amount is not a trailing-quarter total. Missing amounts are not treated as zero, and no adjustment to reported profit is made by this table.
The effect of changing growth, margins and valuation assumptions.
Change the margin alone until the model value at 2027-09-15 equals the latest close of $89.25. Financial period 2026-07-31. All other published assumptions remain fixed. This is a conditional test, not a claim about what the market expects.
USD per share at the published target date. Each test changes one assumption, holding the others fixed. Dots mark the published target; the dashed line marks the latest close. Ranges are not probabilities.
P/E ยฑ20% creates the largest change in this one-assumption test. 3 of 3 tests cross the latest share price. These ranges are sensitivity checks, not probabilities.
A large range means the conclusion depends heavily on the selected inputs. More methods agreeing does not prove those shared inputs are correct.
Inspect the target assumptions โUses current positive statement earnings and peer P/E. Different earnings definitions or growth prospects can explain the gap.
Uses recorded common equity. Book value can differ considerably from realisable asset value.
Current-value references using the starting inputs. The published target has a future date and its own assumptions. These references are not averaged into it. User edits in the valuation section remain separate.
Use different methods to test the price. Compare their assumptions and results before drawing a conclusion.
| Method | Starting value | Basis |
|---|---|---|
| Peer price / earnings | $122.38 | Trailing statement EPS of $3.9151 ร the selected P/E. The starting multiple is the median of 12 same-industry peers. |
| Peer price / common book | $64.46 | Reported equity less preferred stock, per current share, multiplied by the median common-book multiple of 5 peers. |
Dots mark the selected values; bars show the lower and higher illustrations. The dashed line marks the latest close. These ranges are not confidence intervals. Several methods use the same financial inputs and peers; agreement is not independent confirmation. All are shown per common share in USD.
Funding needs, adverse conditions and the effect of a holding on your portfolio.
Review borrowing and company disclosures alongside interest rates and commodity markets.
Balance-sheet figures from 2026-09-11. Cash may be needed to run the business.
Illustration: interest rates rise by 1 percentage point on the stated portion of debt. Existing fixed rates and hedges may delay or reduce the effect. This is not a debt-maturity schedule.
Each dot is one shared week. Bond and commodity funds are price proxies; their returns also reflect fund construction and expenses.
Correlation ranges from โ1 to +1. A relationship can change and may reflect broader market movements. It does not prove a customer, currency or commodity exposure.
Customer Concentration and Retention - a number of our customers operate in similar cyclical industries. Changes in economic conditions in these industries could impact our sales.Read in the filing โ
โข legal and regulatory requirements, including import, export, defense regulations, anti-corruption laws and foreign exchange controls;Read in the filing โ
The Companyโs exposure to market risk for changes in interest rates primarily relates to debt obligations that are at variable rates, as well as the potential increase in the fair value of long-term debt resulting from a potential decrease in interest rates. As of July 31, 2025, the Companyโs financial liabilities with exposure to changes in interest rates consisted of $60.0 million outstanding on the Companyโs unsecured revolving credit facility, โฌ80.0 million, or $91.6 million, of a variable rate term loan, $200.0 million of a variable rate term loan and ยฅ2.0 billion, or $13.4 million, of vaโฆRead in the filing โ
We obtain raw materials, including steel, filter media, petroleum-based products and other components from third-party suppliers. We often concentrate our sourcing of some materials from one supplier or a few suppliers. We rely, in part, on our suppliers to ensure they meet required quality and delivery standards. An unanticipated delay in delivery by our suppliers could result in the inability to deliver our products on time and to meet the expectations of our customers. We could experience an increase in the costs of doing business, including increasing raw material prices and transportationโฆRead in the filing โ
Compare your current mix with a proposed holding in DCI. Holdings entered here are used for this calculation and are not saved.
Shows contributions to variance using shared weekly observations. A negative contribution means a holding offset some movements over this period.
Results against forecasts, your saved research, review decisions and data checks.
No material change requires a new assessment.
Understand the business. Review sales, profit and cash generation. Open the evidence link beneath each conclusion.
Test the assumptions. A valuation is a scenario. Change growth, margins and the discount rate to see how much the result depends on them.
Keep track. Save your own reasons and conditions. Revisit them after results. Figures show their observation dates. Data notes explain unavailable information.
Follow the forecasts behind the current assessment. Earlier versions remain in the full record. Price movements alone do not settle the business case.
| Measure / period | Forecast | Reported | Difference | Status / recorded |
|---|---|---|---|---|
| Sales2027-07-31 | $4,075,454,844 | Awaiting full-year result | โ | Waiting for resultsRecorded 2026-09-16 ยท Live ยท Reporting period had begun |
| Net income2027-07-31 | $451,096,246 | Awaiting full-year result | โ | Waiting for resultsRecorded 2026-09-16 ยท Live ยท Reporting period had begun |
| Sales2028-07-31 | $4,274,586,212 | Awaiting full-year result | โ | Waiting for resultsRecorded 2026-09-16 ยท Live |
| Net income2028-07-31 | $473,137,323 | Awaiting full-year result | โ | Waiting for resultsRecorded 2026-09-16 ยท Live |
Forecasts are frozen when recorded. Actuals use the matching full financial year or four reported quarters, on the forecast's stated profit basis. Dated results are retained; restatements are recorded separately. Forecasts made after the period began are identified. Revisions, overlapping periods and preview records are not independent evidence of forecasting skill.
Set measurable conditions for your investment case, then compare them with new company data.
Margin and cash conditions use the latest trailing statements where available. Revenue growth compares reported annual years. Factor figures through 2026-09-11.
Through 2026-07-31. Compare the next quarter with the same period a year earlier. Check whether growth speeds up or slows down.
Through 2026-07-31. Check whether the next results retain the latest margin. Separate recurring improvements from one-off gains.
Compare growth with the previous year and the current forecast.
Check whether operating profit keeps pace with sales.
Check whether profit is turning into operating cash.
Check whether debt is falling relative to earnings.
Check whether analysts raised or lowered the same fiscal-period estimate.
Keep a dated copy of your reasoning, valuation assumptions and conditions. New saves preserve earlier versions.
Conditions are checked against the latest available figures when you open this report. This does not place trades or send email alerts.
Sign in to keep your research and review changes over time.
Stored financial statements changed; the revised figures need checking. The model version changed. The published model version has been replaced. Record the new calculation basis even if the rating is unchanged. Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance, business evidence, earnings support.
| Measure | At publication | Latest | Change |
|---|---|---|---|
| Quarterly sales growth | 7.96% | 7.96% | Within starting range |
| Quarterly operating margin | 17.24% | 17.24% | Within starting range |
| Operating cash / profit | 1.09ร | 1.09ร | Within starting range |
| Net debt / EBITDA | 1.51ร | 1.51ร | Within starting range |
Recheck the business, assumptions and valuation. The target keeps its original end date until that horizon expires. A routine data refresh does not issue a new rating.
New results, revised financial statements, a material company disclosure, a change in the valuation method or failing cash and debt checks trigger a review. Same-period guidance revisions require at least 5% for EPS or 10% for other measures. Consensus EPS revisions require 10% and at least three analysts.
A price-only signal must persist for 14 days across separate completed weeks. Rating changes normally wait at least 30 days and must clear five-percentage-point entry and exit bands. A direct Buy-to-Sell or Sell-to-Buy change requires material company evidence.
Missing essential data, an unresolved material event or a share-basis change can suspend a call immediately. An expired target or data check more than three days overdue is not shown as an active rating. Original assessments remain in the record.
A reviewed target normally changes only by 5% or more; a rating change or an expired horizon can also require a new assessment. These are explicit research-policy thresholds, not statistically proven trading rules. Policy sm-review-2-research.
| Published | Rating | Target | Target date | Reason |
|---|---|---|---|---|
| 2026-09-16 ยท 3 โ | Hold | $87.62 | 2027-09-15 | Stored financial statements changed; the revised figures need checking. The model version changed. The published model version has been replaced. Record the new calculation basis even if the rating is unchanged. Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance, business evidence, earnings support. |
| 2026-09-16 ยท 2 โ | Hold | $87.62 | 2027-09-15 | The model version changed. The published model version has been replaced. Record the new calculation basis even if the rating is unchanged. Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance, business evidence, earnings support. |
| 2026-09-15 ยท 1 โ | Hold | $87.62 | 2027-09-15 | First recorded assessment. |
Stored financial statements changed; the revised figures need checking.
Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance, business evidence, earnings support.
Stored financial statements changed; the revised figures need checking.
The model version changed.
The published model version has been replaced. Record the new calculation basis even if the rating is unchanged.
Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance, business evidence, earnings support.
The model version changed.
The published model version has been replaced. Record the new calculation basis even if the rating is unchanged.
Neither a positive nor a negative classification meets the stated requirements. Review price and return, downside balance, business evidence, earnings support.
First recorded assessment.
Forecast errors in sales, operating profit and cash are recorded separately from share-price outcomes. Preview records never enter live accuracy figures.
There are no completed live operating forecasts to assess yet. A useful record takes time; historical fits and preview scenarios are not substituted for it.
| Recorded / model | Period ending | Measure | Forecast (USD) | Actual (USD) | Status |
|---|---|---|---|---|---|
| 2026-09-15business-forecasts-2-period-basis ยท live | 2027-07-31 | Sales | 4,075,454,844 | โ | Waiting for results |
| 2026-09-15business-forecasts-2-period-basis ยท live | 2027-07-31 | Net income | 451,096,246 | โ | Waiting for results |
| 2026-09-15business-forecasts-2-period-basis ยท live | 2028-07-31 | Sales | 4,274,586,212 | โ | Waiting for results |
| 2026-09-15business-forecasts-2-period-basis ยท live | 2028-07-31 | Net income | 473,137,323 | โ | Waiting for results |
| 2026-09-16business-forecasts-2-period-basis ยท live | 2027-07-31 | Sales | 4,075,454,844 | โ | Waiting for results |
| 2026-09-16business-forecasts-2-period-basis ยท live | 2027-07-31 | Net income | 451,096,246 | โ | Waiting for results |
| 2026-09-16business-forecasts-2-period-basis ยท live | 2028-07-31 | Sales | 4,274,586,212 | โ | Waiting for results |
| 2026-09-16business-forecasts-2-period-basis ยท live | 2028-07-31 | Net income | 473,137,323 | โ | Waiting for results |
| 2026-09-16business-forecasts-2-period-basis ยท live | 2027-07-31 | Sales | 4,075,454,844 | โ | Waiting for results |
| 2026-09-16business-forecasts-2-period-basis ยท live | 2027-07-31 | Net income | 451,096,246 | โ | Waiting for results |
| 2026-09-16business-forecasts-2-period-basis ยท live | 2028-07-31 | Sales | 4,274,586,212 | โ | Waiting for results |
| 2026-09-16business-forecasts-2-period-basis ยท live | 2028-07-31 | Net income | 473,137,323 | โ | Waiting for results |
Forecasts are frozen when recorded. Actuals use the matching full financial year or four reported quarters, on the forecast's stated profit basis. Dated results are retained; restatements are recorded separately. Forecasts made after the period began are identified. Revisions, overlapping periods and preview records are not independent evidence of forecasting skill. Read the share-price assessment record โ
Automated checks cover dates, units and accounting relationships. A matched filing fact confirms that reported amount and basis; it does not establish recurring earnings or validate a forecast.
Value operating cash flow or comparable earnings; deduct debt and other ownership claims where appropriate.
17 of 18 checks passed. 60 financial cells have a matched filing basis; 49 other recorded cells have not been matched to a standard filing fact here. Missing company-specific measures and forecast coverage are explained in their sections.
| Check | Status | What it checks |
|---|---|---|
| Price observations | Passed | Prices must be positive, finite, in date order and have no duplicate weeks. |
| Historical price basis | Passed | No material split or distribution discontinuity was found between the two price histories. |
| Price date | Passed | The latest completed close must be no more than 14 days old. |
| Business model | Passed | Value operating cash flow or comparable earnings; deduct debt and other ownership claims where appropriate. |
| Earnings and share units | Passed | Earnings, profit and weighted shares are reconciled before per-share growth is used. No conflicting per-share comparisons were found. |
| Balance-sheet totals | Passed | Assets must reconcile to liabilities and equity, allowing separately reported minority interests and 1% rounding tolerance. No conflicting complete balance sheets were found. |
| Consolidated depreciation | Passed | Depreciation from a cash-flow reconciliation is distinguished from expense components. Conflicting amounts are excluded until the statement establishes their scope. No unresolved component-versus-total conflict was found. |
| Statement currency | Passed | Valuation cash flows and the share price must use the same currency; amounts are not silently converted. |
| Publication dates | Passed | Future financial periods and future filing dates cannot enter the assessment. |
| Known reporting dates | Passed | 0 of the latest four quarters have no stored publication date. These cannot support a point-in-time claim. |
| Cash-flow identities | Passed | Operating cash plus negative capital spending must equal cash after capital spending. All comparable stored periods reconcile within 1%. |
| Operating-profit basis | Passed | 4 of the latest four quarters have an explicit reported operating-income basis. EBIT may include non-operating items; it is not automatically treated as operating income. |
| Filed and stored totals | Review needed | 1 trailing input totals differ from the stored snapshot. The matched filed totals are used in this report; original figures remain in the reconciliation table. |
| Ownership source reconciliation | Passed | No unresolved ownership source conflicts were found. |
| Financial period | Passed | The valuation needs a financial period no more than 150 days old. |
| Corporate-action basis | Passed | A split after the financial period needs a reviewed reconciliation of shares, earnings per share and the quoted price. |
| Share count | Passed | Per-share enterprise and book values require a positive current share count. |
| Ownership and debt amounts | Passed | Debt, cash, preferred stock and minority interests cannot be negative. |
| Input | Stored snapshot | Matched filed quarters |
|---|---|---|
| Operating income | 599900000 | 605800000 |
SM Virtual Analyst is an automated research report for general information. Its model ratings and price targets are not personal investment advice, an offer to trade, or a guarantee of value or return. The report does not consider your financial circumstances, objectives, tax position or capacity for loss.
Reported figures can be delayed, incomplete, corrected or restated. Source checks confirm specific reported amounts and accounting relationships; they do not audit a company, establish recurring earnings or prove that a forecast is accurate. Missing information is not assumed to be zero unless a particular illustration expressly says so.
Valuations depend on the stated business model, assumptions and available data. Scenario ranges are illustrations, not probabilities, confidence intervals or limits on loss. Ratings use the disclosed review policy; they are not an independently validated prediction of future returns. Past performance and historical comparisons do not predict future results. An investment can lose its entire value.
Prices, financial periods, publication dates, model versions and review dates are shown in the report. The dated published assessment is separate from editable valuation illustrations. Unless expressly stated otherwise, price comparisons exclude dividends, fees and taxes. Check the latest company filings and subsequent events before making a decision, and seek qualified advice when needed.
Search by ticker symbol or company name and select a result to open its chart.
Start typing to find a stock or ETF.
Choose one or more countries for market search, or include every covered market.
Currently searching United States